PMC5602351_01
The tumor cells are arranged in broad, pushing, smooth-bordered islands abutted against a lymphocyte rich stroma and seen in 10x (Figure 1) and 20x (Figure 2).
fonc-07-00207-g001.jpg
PMC5602351_01_fonc-07-00207-g001.jpg
F1
The lobules of tumor were surrounded by lymphocytes and plasma cells (Figures 1 and 2).
Figure 1 magnification. The asterisks highlights the lobules of tumor in the images. These are surrounded by lymphocytes and plasma cells, as indicated by the arrow.
fonc-07-00207-g002.jpg
PMC5602351_01_fonc-07-00207-g002.jpg
F2
The lobules of tumor were surrounded by lymphocytes and plasma cells (Figures 1 and 2).
The neoplastic cells are strongly immunoreactive for pancytokeratin. Lymphocytes are negative.
fonc-07-00207-g003.jpg
PMC5602351_01_fonc-07-00207-g003.jpg
F3
The neoplastic cells were strongly immunoreactive for pancytokeratin and p63, as shown in Figures 3 and 4.
The tumor cell shows strong immunoreactivity to p63. Lymphocytes lack reactivity.
fonc-07-00207-g004.jpg
PMC5602351_01_fonc-07-00207-g004.jpg
F4
The neoplastic cells were strongly immunoreactive for pancytokeratin and p63, as shown in Figures 3 and 4.
Tumors cells that demonstrate strong positivity to CD5, also marking background lymphocytes.
fonc-07-00207-g005.jpg
PMC5602351_01_fonc-07-00207-g005.jpg
F5
T lymphocytes (Figure 5). The neoplastic cells were non-reactive with TTF1 and thyroglobulin.
Coronal section of radiotherapy plan showing 60 Gy dose line in green and boost volume in red.
fonc-07-00207-g006.jpg
PMC5602351_01_fonc-07-00207-g006.jpg
F6
A coronal section of the radiotherapy plan is shown in Figure 6.